A Case Report on Pulmonary Tuberculosis Associated with Deep Vein Thrombosis
Abstract
Public health problems such as tuberculosis remain a major concern, especially in developing countries. According to WHO (World Health Organization), for every second someone gets infected with tuberculosis. India is the second most populated nation in the world contributes to 23% of TB incident cases annually out of 9.6 million worldwide. The overall morbidity and mortality associated with TB are reduced with early initiation of anti-TB treatment. In India, most antituberculosis regimens are Rifampicin-based under the Revised National Tuberculosis Control Program (RNTCP). Despite its rarity, deep venous thrombosis (DVT) should be considered especially in those with severe disseminated or pulmonary tuberculosis. This case report describes a 31-year-old female with pulmonary tuberculosis initiated on rifampicin-based antituberculosis treatment presented with deep vein thrombosis.
Keywords: Tuberculosis, Deep vein thrombosis, pulmonary tuberculosis
Keywords:
Tuberculosis, Deep vein thrombosis, pulmonary tuberculosisDOI
https://doi.org/10.22270/jddt.v13i2.5740References
Al-Tawfiq JA, "Multifocal systemic tuberculosis: the many faces of an old nemesis" Med Sci Monit, 2007; 13(4):56-60.
Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J, "The Diagnosis and Treatment of Tuberculosis" Dtsch Arztebl Int, 2019; 116(43):729-735. https://doi.org/10.3238/arztebl.2019.0729
Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA, "Structural mechanism for rifampicin inhibition of bacterial rna polymerase" Cell, 2001; 104(6):901-12. https://doi.org/10.1016/S0092-8674(01)00286-0
Ambrosetti M, Ferrarese M, Codecasa LR, Besozzi G, Sarassi A, Viggiani P, Migliori GB; AIPO/SMIRA TB Study Group, "Incidence of venous thromboembolism in tuberculosis patients" Respiration, 2006; 73(3):396. https://doi.org/10.1159/000091188
Gogna A, Pradhan GR, Sinha RS, Gupta B, "Tuberculosis presenting as deep vein thrombosis" Postgrad Med J, 1999; 75(880):104-105. https://doi.org/10.1136/pgmj.75.880.104
Saluja M, Swami YK, Chittora S, Vimlani H, "Rifampicin containing ATT regimen as an emerging cause of thromboembolic complications" J. Evid. Based Med. Healthc, 2018; 5(45):3164-3167. https://doi.org/10.18410/jebmh/2018/644
Gupta A, Mrigpuri P, Faye A, Bandyopadhyay D, Singla R, "Pulmonary tuberculosis - An emerging risk factor for venous thromboembolism: A case series and review of literature" Lung India, 2017; 34(1):65-69. https://doi.org/10.4103/0970-2113.197110
White NW, "Venous thrombosis and Rifampicin" Lancet, 1989; 2(8660):434-5. https://doi.org/10.1016/S0140-6736(89)90603-X
Turken O, Kunter E, Sezer M, Solmazgul E, Cerrahoglu K, Bozkanat E, Ozturk A, Ilvan A, "Hemostatic changes in active pulmonary tuberculosis" Int J Tuberc Lung Dis, 2002; 6(10):927-32. https://doi.org/10.5588/09640569513039
Published
Abstract Display: 387 
PDF Downloads: 397 PDF Downloads: 168 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.